Bill C-378
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
1st Session, 39th Parliament,
55 Elizabeth II, 2006
house of commons of canada
BILL C-378
An Act to amend the Food and Drugs Act and the Food and Drug Regulations (drug export restrictions)
Her Majesty, by and with the advice and consent of the Senate and House of Commons of Canada, enacts as follows:
R.S., c. F-27
FOOD AND DRUGS ACT
1. Section 30 of the Food and Drugs Act is amended by adding the following after subsection (2):
Export
(2.1) The Governor in Council may, where the Governor in Council deems it necessary for the protection of human health, make regulations governing the export from Canada of any drug described in Schedule D or F, including regulations
(a) prescribing the terms and conditions under which the export from Canada of any drug described in Schedule D or F may be permitted; and
(b) exempting any person or goods or any class of persons or goods from the prohibition against export set out in section 37.1.
2. The Act is amended by adding the following after section 31.1:
Offences relating to export of drugs
31.2 Every person who exports from Canada a drug that is prohibited from being exported under this Act or the regulations is guilty of an offence and liable
(a) on summary conviction, to a fine not exceeding $50,000 or to imprisonment for a term not exceeding six months or to both; or
(b) on conviction by indictment, to a fine not exceeding $250,000 or to imprisonment for a term not exceeding three years or to both.
3. The Act is amended by adding the following after section 37:
Prohibition against export
37.1 No person shall, except as permitted under the regulations, export from Canada any drug described in Schedule D or F.
C.R.C., c. 870
FOOD AND DRUG REGULATIONS
4. The Food and Drug Regulations are amended by adding the following after section C.01.049:
C.01.050. A Schedule F drug may be exported from Canada if
(a) the drug is contained in a substance that has been sold pursuant to a verbal or written prescription received by the seller under subsection C.01.041(1.1);
(b) the drug has been sold pursuant to section C.01.046;
(c) the drug is exported from Canada by the manufacturer of the drug or by the manufacturer's agent;
(d) the drug is not manufactured or sold for consumption in Canada and it complies with the conditions set out in subsection 37(1) of the Act; or
(e) the drug is exported pursuant to sections 21.01 to 21.2 of the Patent Act.
5. The Regulations are amended by adding the following after section C.04.683:
C.04.684. A Schedule D drug may be exported from Canada if
(a) the drug is exported from Canada by the manufacturer of the drug or by the manufacturer's agent;
(b) the drug is not manufactured or sold for consumption in Canada and it complies with the conditions set out in subsection 37(1) of the Act; or
(c) the drug is exported pursuant to sections 21.01 to 21.2 of the Patent Act.
Published under authority of the Speaker of the House of Commons
Available from:
Publishing and Depository Services
Public Works and Government Services Canada
Available from:
Publishing and Depository Services
Public Works and Government Services Canada